top of page

일정

  • 등록

  • 오프닝 세션

  • Annex 1: Key Regulatory Shifts and Their Impact on Facilities

  • Implementation Challenges and Solutions in Aseptic Fill-Finish Facilities

  • 휴식 시간

  • Environmental Monitoring (Performance Qualification) Approaches vs. Real World Cases: Insights Uncover Myths

  • Strengthening Smoke Study Practices: A Case Study in Aseptic Manufacturing

  • Integrating Risk-Based Approaches in Contamination Control Strategy: An Inspector’s View

  • Q&A and Panel Discussion

  • 점심 시간

  • Closed Systems, Robotics, and Isolator Technologies

  • Aseptic Manufacturing for mRNA, ADCs, and Novel Biologics

  • 휴식 시간

  • Adopting USP Chapter <86>: Efficiently Transitioning to Recombinant Endotoxin Testing and Case Study

  • Building a Culture of Compliance and Continuous Improvement

  • Q&A and Panel Discussion

  • Common Data Integrity Pitfalls Observed During Inspections: Intentional, Unintentional and Systemic Vulnerabilities

  • Audit Findings: Common Data Integrity Gaps

  • 휴식 시간

  • Geopolitical impact on supply chain of medicines for Aseptic Manufacturers

  • Cold Chain Management for Biologics and Cell Therapies

  • Q&A and Panel Discussion

  • 점심 시간

  • Primary Packaging Compatibility, Sterility and The Use For High Potent Products

  • CCS in Sterile Packaging & Compliance Update

  • RTU Primary Packaging and Aseptic Transfer: An Integrated Perspective

  • 휴식 시간

  • Aseptic Processing for ATMPs: Facility and Process Design

  • Regulatory & Ecosystem Framework Updates on Regenerative Medicine: A RMAF Korea Perspective

  • Regulatory and Quality Considerations for CGT Manufacturing: A Japan Perspective

  • Q&A and Panel Discussion

   일정은 변경될 수 있습니다.*  

해당 컨퍼런스에서는 한국어 동시통역 서비스가 제공될 예정입니다

Parenteral Drug Association Inc.

Business Address: 
PDA Global Headquarters
Bethesda Towers
4350 East West Highway, Suite 600
Bethesda, MD 20814 USA

© 2025 Parenteral Drug Association. All rights reserved

 

bottom of page